StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) stock

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$267.07+7.79 (+3.00%)

Close on Nov 12, 2026Market cap $16.55BP/E 21.7Yield –

Ascendis Pharma A/S gross margin

Gross margin is gross profit as a percentage of revenue.

Ascendis Pharma A/S's gross margin for the twelve months ending Jun 30, 2026 was 91.3%. For fiscal 2025 it was 86.8%, against 87.8% the year before. The highest annual figure on record is 100.0% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202586.8%−1.0
FY2024Dec 31, 202487.8%+4.5
FY2023Dec 31, 202383.4%+7.1
FY2022Dec 31, 202276.3%+21.6
FY2021Dec 31, 202154.7%−45.3
FY2020Dec 31, 2020100.0%+0.0
FY2019Dec 31, 2019100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202691.8%+11.7
Q1 FY2026Mar 31, 202692.9%+10.2
Q4 FY2025Dec 31, 202590.5%−1.5
Q3 FY2025Sep 30, 202589.5%+8.9
Q2 FY2025Jun 30, 202580.1%+12.0
Q1 FY2025Mar 31, 202582.6%−9.5
Q4 FY2024Dec 31, 202491.9%+6.1
Q3 FY2024Sep 30, 202480.6%−4.0
Q2 FY2024Jun 30, 202468.2%−4.6
Q1 FY2024Mar 31, 202492.1%+5.9
Q4 FY2023Dec 31, 202385.9%+8.2
Q3 FY2023Sep 30, 202384.6%−4.3
Q2 FY2023Jun 30, 202372.7%−9.7
Q1 FY2023Mar 31, 202386.2%+48.4
Q4 FY2022Dec 31, 202277.7%+49.6
Q3 FY2022Sep 30, 202288.9%−11.1
Q2 FY2022Jun 30, 202282.4%−17.6
Q1 FY2022Mar 31, 202237.8%−62.2
Q4 FY2021Dec 31, 202128.1%–
Q3 FY2021Sep 30, 2021100.0%–
Q2 FY2021Jun 30, 2021100.0%–
Q1 FY2021Mar 31, 2021100.0%–

More Ascendis Pharma A/S figures

See a number that looks wrong?